Abstract
The primary goal of this study was to determine the impact of mergers and acquisitions (M&A) and the environmental, social, and governance (ESG) sustainability scores of companies. In this regard, efforts to measure and analyze the evolution of a company’s performance, taking into account financial and non-financial measures using a score function, are adapted to the pharmaceutical sector. The sample consisted of 100 leading pharmaceutical companies, ranked by stock market capitalization, who registered 30% (n = 492) of the total M&A transactions over the study period (2010–2020). There was a direct and positive link between the M&A process and the evolution of company performance. The ESG score, as an indicator for measuring sustainability, has a positive and direct impact on company performance, indicating that a high ESG score determines an increase in company performance. A similar impact is identified for companies involved in M&A processes, meaning that companies in the pharmaceutical sector tend to register a performance improvement.
Funder
Universitatea "Lucian Blaga" din Sibiu
Subject
Management, Monitoring, Policy and Law,Renewable Energy, Sustainability and the Environment,Geography, Planning and Development
Reference68 articles.
1. Critical success factors through the mergers and acquisitions process: Revealing pre-and post-M&A connections for improved performance;Gomes;Thunderbird Int. Bus. Rev.,2013
2. https://imaa-institute.org/mergers-and-acquisitions-statistics/
3. The new M&A playbook;Christensen;Harv. Bus. Rev.,2011
4. Reasons for Frequent Failure in Mergers and Acquisitions: A Comprehensive Analysis;Straub,2007
5. Performance assessment of mergers and acquisitions: Evidence from Denmarkhttp://www.g-casa.com/PaperDatabase.htm
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献